Treatment of secondary peritonitis: Is a less expensive broad-spectrum antibiotic as effective as a carbapenem?

Digestive Surgery

Volumn 20, Issue 5, 2003, Pages 415-420

  Genné, Daniel ^a,b   Menetrey, A ^a   Jaquet, A ^a   Indino, P ^a   Senechaud C ^a   Siegrist, H H ^a  

^a Hopital de la Chaux de Fonds   (Switzerland)

^b Hôpital de la Ville   (Switzerland)

Author keywords

Broad spectrum antibiotic; Secondary peritonitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL FLUID; PERITONITIS; POSTOPERATIVE INFECTION; REOPERATION; TREATMENT FAILURE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIPENEM; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERITONITIS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0141792837     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072709     Document Type: Article

References (20)

1. Brismar B, Sjöstedt S, Nord KC: Peritonitis, pancreatitis and intra-abdominal abscesses; in Berkley SF, Carbon CJ, Clumeck N, Durack DT, Finch RG, Kiehn TE, Louria DB, McAdam K, Norrby SR, Solberg CO, Verhoef J (eds): Infectious Diseases. London, Harcourt Publishers, 1999, pp 2.38.1-2.38.3.
2. Gallinaro R, Polk H: Intra-abdominal sepsis: The role of surgery. Baillières Clin Gastroenterol 1991;5:611-637.
3. Lorber B, Swenson RM: The bacteriology of intra-abdominal infections. Surg Clin North Am 1975;55:1349-1354.
4. McClean KL, Sheehan GJ, Harding GKM: Intra-abdominal infection: A review. Clin Infect Dis 1994;19:100-116.
5. Brismar B, Malmborg AS, Tuncrall G: Meronem versus imipenem/cilastin in the treatment of intra-abdominal infections. Report from a Swedish study group. J Antimicrob Chemother 1995;35:139-148.
6. Brismar B, Malmoborg AS, Tunevall G, Wretlind B, Bergman L: Piperacillin/tazobactam versus imipenem/cilastin for treatment of intra-abdominal infections. Antimicrob Agents Chemother 1992;36:2766-2773.
7. Wilson SE, Nord CE: Clinical trials of extended spectrum penicillin/betalactamase inhibitors in the treatment of intra-abdominal infections: European and American experience. Am J Surg 1995;169(suppl 5A):21-26.
8. NCCLS: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, ed 7. NCCLS document M2-A7. Wayne, NCCLS, 2000.
9. Wexler HM: Susceptibility testing of anaerobic bacteria: The state of the art. Clin Infect Dis 1993;4:328-333.
10. Finegold SM: Abdominal and perineal infections; in Finegold SM (ed): Anaerobic Bacteria in Human Disease. New York, Academic Press, 1977, pp 257-313.
11. Sawyer RG, Rosenlof LK, Adams RB, May AK, Spengler MD, Pruett T: Peritonitis into 1990s: Changing strategies in the critically ill. Am Surg 1992;58:82-87.
12. Mosdell DM, Morris DM, Voltura A: Antibiotic treatment for surgical peritonitis. Ann Surg 1991;214:543-549.
13. Dupont H, Carbon C, Carlet J: Severe generalized peritonitis study group. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial. Antimicrob Agents Chemother 2000;44:2028-2033.
14. Rotstein OD, Pruett TL, Simmons RL: Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis 1985;7:151-170.
15. Weinstein WN, Onderdonk AB, Bartlett JG, Gorbach SL: Experimental intra-abdominal abscesses in rats: Development of an experimental model. Infect Immun 1974;10:1250-1255.
16. Johnson CC, Baldessarre J, Levison ME: Peritonitis: Update on pathophysiology, clinical manifestation, and management. Clin Infect Dis 1997;24:1035-1045.
17. Ricart E, Soriano G, Novella MT, Ortiz J, Sabat M, Kolle L, Sola-Vera J, Minana J, Dedeu JM, Gomez C, Barrio JL, Guarner C: Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000;32:596-602.
18. Heloury Y, Baron M, Bourgoin S, Wetzel O, Lejus C, Plattner V: Medical treatment of postappendectomy intraperitoneal abscess in children. Eur J Pediatr Surg 1995;5:149-151.
19. Vanhoof R, Carpentier M, Delannoy P, Fagnart O, Lontie M, Mans I, Nyssen HJ, Van Nimmen L: Study of the in-vitro activity of amoxicillin/clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated from urine specimens. Acta Clin Belg 2001;56: 32-37.
20. Gorbach SL: Intraabdominal infections. Clin Infect Dis 1993;17:961-967.